Clinical trials of pain medication often produce less-than-ideal results because the control group, or patients receiving a placebo, often improve more than expected. A team of researchers will explore how the design of chronic and acute pain trials can be improved.
Related Articles on Pain Management:
Pieces of the Puzzle: Creating a Multidisciplinary Approach to Pain Management
Anesthesiologist Compensation and Reimbursement in 2011: 10 Recent Findings
Spine Pain Management Adds to Leadership Team
University of Rochester gets $4.5M From FDA to Study Clinical Pain Trials
The FDA will grant the University of Rochester Medical Center a $4.5 million grant over five years to study different approaches to improve methods used to evaluate and approve treatments for acute and chronic pain, according to a University news release.
Staying ahead of OBBBA: Tools and strategies to protect patients and strengthen RCM
Recommended Whitepaper